Quarter
Charts
πŸ‡ΊπŸ‡ΈUS Markets

LivaNova PLC

LIVN

CIK 0001639691 Β· Quarterly mode Β· latest period FY2025 (Q4) (ending 2025-12-31) Β· sourced from SEC EDGAR

At a glance Β· FY2025 (Q4)

Revenue
$361M
↑+12.1% +$39Mvs FY2024 (Q4)
Operating Income
$43M
↑+15.0% +$6Mvs FY2024 (Q4)
Net Income
$32M
↑+53.5% +$11Mvs FY2024 (Q4)
Gross Profit
$240M
↑+14.1% +$30Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot Β· latest annual filed values Β· S&P 500 calibration

Average
56/100
  • Profitability
    25ROIC 9.9% (10% = solid, 20%+ = moat)
  • Liquidity
    43Current Ratio 1.36 (above 1.5 = solid)
  • Leverage
    84D/E 0.31 (under 0.5 = conservative)
  • Efficiency
    26Asset Turnover 0.54x (1.0+ = capital-efficient)
  • Growth
    57Revenue YoY +12.1% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 11.8% Β· trend +4.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project LIVN's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 58.6%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≀ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$105.96
Total enterprise IV
$5.78B
Diluted shares
0.05B
Terminal PV
$4.49B (78% of total)
Year-5 FCF
$529M
YearProjected FCFDiscounted PV
+1$217M$197M
+2$271M$224M
+3$338M$254M
+4$423M$289M
+5$529M$328M
Terminal$7.23B$4.49B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target β€” and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation Β· trailing 4 quarters

how the company spent its cash
Capex (TTM)
$81M
investment in PP&E
Stock buybacks (TTM)
β€”
share count reduction
Stock-based comp (TTM)
$36M
non-cash dilution

Balance sheet Β· 2025-12-31

latest filed snapshot
Total assets
$2.61B
everything owned
Total liabilities
$1.41B
everything owed
Stockholders' equity
$1.20B
shareholder claim
Net debt
$-259M
Net cash position ($259M)

Recent performance Β· 52 quarters

Revenue↑+12.1% +$39M
$361M
Net Income↓-18.7% -$6M
$27M
Free Cash Flow↓-26.6% -$18M
$50M
Operating Margin↑+0.3pts
11.8%

Drill down